# Effects of Amygdala Neurofeedback on Depressive Symptoms

> **NCT02709161** · NA · TERMINATED · sponsor: **Kymberly Young** · enrollment: 36 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DEVICE:** real-time fMRI neurofeedback: Amygdala
- **DEVICE:** real-time fMRI neurofeedback: HIPS

## Key facts

- **NCT ID:** NCT02709161
- **Lead sponsor:** Kymberly Young
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** The grant funding ran out
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709161, "Effects of Amygdala Neurofeedback on Depressive Symptoms". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02709161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*